Summary:
Click image to enlarge
A Randomized,Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100ug and Salmeterol Xinafoate 50 ug Inhalation Powder Compared with Advair Diskus 100/50 in Subjects with Asthma.
Qualified Participants Must:
• Male or Female, 18 years old and above
•
Non-smokers or former smokers
•
Have diagnosis of Asthma
Qualified Participants May Receive:
Compensation for each visit completed
Study medications, including albuterol (for free during the study)